Related Experiment Video
Updated: Feb 14, 2026

Isolation of Human Myoblasts, Assessment of Myogenic Differentiation, and Store-operated Calcium Entry Measurement
Published on: July 26, 2017
PIP5K1α promotes myogenic differentiation via AKT activation and calcium release
Xiaofan Chen1, Jun Wan2, Bo Yu1,3
1Shenzhen Key Laboratory for Translational Medicine of Dermatology, Biomedical Research Institute, Shenzhen Peking University-the Hong Kong University of Science and Technology Medical Center, Lianhua Road 1120, Shenzhen, 518036, Guangdong Province, China.
Background:
Skeletal muscle satellite cell-derived myoblasts are mainly responsible for postnatal muscle growth and injury-induced regeneration. Many intracellular signaling pathways are essential for myogenic differentiation, while a number of kinases are involved in this modulation process. Type I phosphatidylinositol 4-phosphate 5-kinase (PIP5KI) was identified as one of the key kinases involved in myogenic differentiation, but the underlying molecular mechanism is still unclear.
Methods:
PIP5K1α was quantified by quantitative reverse transcriptase PCR and western blot assay. Expression levels of myogenin and myosin heavy chain, which showed significant downregulation in PIP5K1α siRNA-mediated knockdown cells in western blot analysis, were confirmed by immunostaining. Phosphatidylinositol 4,5-bisphosphate in PIP5K1α siRNA-mediated knockdown cells was also measured by the PI(4,5)P2 Mass ELISA Kit. C2C12 cells were overexpressed with different forms of AKT, followed by western blot analysis on myogenin and myosin heavy chain, which reveals their function in myogenic differentiation. FLIPR assays are used to test the release of calcium in PIP5K1α siRNA-mediated knockdown cells after histamine or bradykinin treatment. Statistical significances between groups were determined by two-tailed Student's t test.
Results:
Since PIP5K1α was the major form in skeletal muscle, knockdown of PIP5K1α consistently inhibited myogenic differentiation while overexpression of PIP5K1α promoted differentiation and rescued the inhibitory effect of the siRNA. PIP5K1α was found to be required for AKT activation and calcium release, both of which were important for skeletal muscle differentiation.
Conclusions:
Taken together, these results suggest that PIP5K1α is an important regulator in myoblast differentiation.
Insights
Type I phosphatidylinositol 4-phosphate 5-kinase alpha (PIP5K1α) is crucial for skeletal muscle growth and regeneration. This study reveals PIP5K1α regulates myoblast differentiation by activating AKT and controlling calcium release.
Area of Science:
- Cell Biology
- Biochemistry
- Muscle Physiology
Background:
- Skeletal muscle satellite cells drive muscle growth and repair.
- Myogenic differentiation involves complex signaling pathways and kinases.
- Type I phosphatidylinositol 4-phosphate 5-kinase (PIP5KI) is implicated in myogenesis, but its mechanism is unclear.
Purpose of the Study:
- To elucidate the role and molecular mechanism of PIP5K1α in skeletal muscle myoblast differentiation.
Main Methods:
- Quantitative PCR and Western blot to assess PIP5K1α expression and myogenic markers.
- Immunostaining to confirm protein expression.
- ELISA kits to measure phosphatidylinositol 4,5-bisphosphate levels.
- AKT overexpression studies and calcium release assays (FLIPR).
Main Results:
- PIP5K1α knockdown inhibited myoblast differentiation, while overexpression promoted it.
- PIP5K1α is essential for AKT activation and calcium release during differentiation.
- Phosphatidylinositol 4,5-bisphosphate levels were affected by PIP5K1α knockdown.
Conclusions:
- PIP5K1α acts as a key regulator of myoblast differentiation.
- The findings highlight PIP5K1α's role in AKT signaling and calcium dynamics in muscle development.
Related Concept Videos
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Modified-Release Drug Delivery Systems: Stimuli-Activated
PI3K/mTOR/AKT Signaling Pathway
Energy-releasing Steps of Glycolysis
The first energy-releasing step—the 6th step of glycolysis...

